98%
921
2 minutes
20
Introduction: Intertrochanteric femur fractures are common in the elderly, with effective pain management being crucial. Fascia iliaca compartment block (FICB) is a well-established method for preoperative analgesia in these patients, but whether liposomal bupivacaine is more effective for this application remains uncertain. This trial aims to evaluate whether liposomal bupivacaine provides superior preoperative analgesia compared to ropivacaine in elderly patients with intertrochanteric femur fracture.
Methods: This randomised controlled trial will include 84 elderly patients with intertrochanteric femur fracture. Participants will be randomised to receive either liposomal bupivacaine (n=42) or ropivacaine (n=42) via FICB. The outcomes assessed will include pain intensity, anxiety, sleep quality, additional analgesic requirements and rebound pain from FICB administration until preprocedure. Additionally, the study will evaluate in-hospital complications, as well as clinical outcomes at 30 days postsurgery.
Ethics And Dissemination: Approved by the Ethics Committee of Sichuan Province Orthopaedic Hospital (Approval No. KY2023-045-01), the study will be published in a peer-reviewed journal. Results will offer evidence-based insights into optimal preoperative analgesia for this patient population.
Trial Registration Number: ChiCTR2400082747.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12273064 | PMC |
http://dx.doi.org/10.1136/bmjopen-2024-093756 | DOI Listing |
Foot Ankle Int
September 2025
Department of Orthopaedic Surgery, St. Luke's University Health Network, Bethlehem, PA, USA.
Background: In response to the opioid epidemic, many surgical specialties have adopted nonopioid pain management strategies. Ultrasound (US)-guided peripheral nerve blocks (PNBs) are effective in reducing pain and opioid consumption postsurgery. Liposomal bupivacaine (LB), shown effective in shoulder surgery, was approved in November 2023 for use in US-guided lower extremity blocks.
View Article and Find Full Text PDFPharm Res
September 2025
Michael E. DeBakey Department of Surgery, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX, 77030, USA.
Purpose: Postsurgical pain (PSP) is a common complication in surgical patients that can progress to chronic pain and opioid dependence. Current analgesics, including opioids and non-opioid agents, are limited by short durations of action and adverse effects. This study reports the development and evaluation of extended-release bupivacaine microparticles (BuMPs) designed to provide sustained local analgesia and improve post-surgical pain management.
View Article and Find Full Text PDFWorld J Transplant
September 2025
Department of Pharmacy, Temple University Hospital, Philadelphia, PA 19140, United States.
Background: Opioids are commonly used for management of post-operative pain in living kidney donors. Reducing exposure to opioids is desirable to minimize risk of dependence and potential side effects such as nausea, vomiting, and constipation which may delay discharge. Liposomal bupivacaine, ketorolac, and scheduled acetaminophen have all demonstrated efficacy for management of post-operative pain in this population.
View Article and Find Full Text PDFReg Anesth Pain Med
August 2025
Department of Anesthesiology, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.
Background: Acute pain after cardiac surgery via median sternotomy is commonly managed with multimodal analgesia, but optimal regional techniques remain uncertain. Superficial parasternal intercostal plane (SPIP) blocks have shown promise for postoperative pain control, with the use of catheters extending these benefits up to three days. This study evaluated the efficacy of single-injection SPIP blocks with liposomal bupivacaine in reducing opioid consumption following cardiac surgery.
View Article and Find Full Text PDFInt J Surg
August 2025
Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.